| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics PLC | Chief Business & Strgy Officer | Jan 15, 2024 | |||
| TRIL | Trillium Therapeutics Inc. | Director | Nov 17, 2021 |
| Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
|---|